↧
$142M Damage Award in Pfizer (NYSE: PFE) Case
Pfizer (NYSE: PFE) was found in violation of US racketeering laws by a federal jury in Boston. The suit, brought on by Kaiser Foundation Health Plan, Inc and Kaiser Foundation Hospitals, was decided by...
View ArticlePfizer (NYSE: PFE) Stops Cancer Drug Testing, Remains Confident in Sutent
Pfizer (NYSE: PFE) has had to stop another cancer drug during a late stage in the process. This time the company halted testing on therapy Sutent has failed due to a high rate of serious problems in...
View ArticleUnusual Move By FDA for Diabetes Drug, Avandia
The Food and Drug Administration has announced today that the controversial diabetes drug Avandia will no longer be available everywhere. According to the announcement from drug regulators in the US...
View Article